Elysium Therapeutics' Angel Round

Elysium Therapeutics raised a round of funding on December 20, 2017. Investors include Mid Atlantic Bio Angels.

Elysium Therapeutics has developed reformulated orally administered opioids so they can't be abused or cause overdose.…

Articles about Elysium Therapeutics' Angel Round: